Table 2.
Indications for home-based monitoring (n=19) and telemonitoring (n=17) in high-risk pregnancies.
| Indications | Home-based monitoring centers, n (%) | Telemonitoring centers, n (%) |
| Fetal growth restriction | 19 (100) | 17 (100) |
| Preterm premature rupture of membranes | 19 (100) | 17 (100) |
| Prolonged prelabor rupture of membranes at term | 5 (26) | 2 (12) |
| Isolated oligohydramnios | 10 (53) | 4 (24) |
| Reduced fetal movement | 15 (79) | 15 (88) |
| Fetal anomalies requiring fetal monitoring | 9 (47) | 3 (18) |
| (Adverse) Obstetrics patient historya | 16 (84) | 15 (88) |
| Hypertensive pregnancy disorders | 15 (79) | 10 (59) |
| Cholestasis of pregnancy | 14 (74) | 5 (29) |
| Other maternal comorbiditiesb | 11 (58) | 4 (24) |
| Social or psychological distress | 11 (58) | 5 (29) |
aFor instance, intrauterine fetal death in a previous pregnancy.
bFor instance, (gestational) diabetes mellitus, kidney disease, and cardiac disease requiring maternal monitoring.